The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents

Brief description of study

The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment of transgender adolescents, in order to provide more comprehensive counsel to patients regarding the possible risks.

Clinical Study Identifier: s23-01455
Principal Investigator: Marissa Lipton.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.